Oxford Global Conferences – 9th Annual Biomarkers Congress

250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

55 presentations, case studies and panel discussions focused on the key issues in biomarker research, personalised healthcare and companion diagnostics

6 Interactive Streams:

Biomarker Discovery & Development
Companion Diagnostics
Biomarker Analysis: Technologies & Platforms
Innovations In Biomarker Research
Clinical Biomarkers
Clinical Trials & Personalised Medicine

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the 9th Annual Biomarkers Congress, taking place on 25 & 26 February 2014 in Manchester.

The increasing interest in biomarker discovery in recent years has pushed biomarker research into the foreground of the modern pharmaceutical industry. New identification technologies have both widened the scope of biomarker research and underlined the need for robust validation, improved predictive value and the clear demonstration of clinical relevance.

The Biomarkers Congress will cover the latest advances in biomarker discovery and verification, including multiplex platforms, nanotechnology platforms and multiple reaction monitoring. Our expert speakers will also discuss efforts to increase biomarker sensitivity and specificity through genomic analysis, systems biology approaches and better sample management. In the Companion Diagnostics stream, presentations will cover Rx/Dx co-development, methods to increase predictive significance and regulatory considerations.

To build on the clinical case studies shared at last year’s event, we are pleased to introduce the co-located Biomarkers in Clinical Development Congress, focusing on the role of biomarkers in clinical decision making, drug efficacy prediction and clinical safety. Key decision makers in personalised medicine will complement these discussions with their insights into adaptive trial design, patient stratification and markers for improved treatment response.

Venue: To celebrate the event’s long-standing association with the city of Manchester, the 2014 Biomarkers Congress will be held at Old Trafford. There will also be an opportunity to participate in an exclusive guided tour through the home of Manchester United.